PDCD1 and cancer: Meta-analysis studies have shown that PD-1 rs2227981, rs36084323 and rs11568821 polymorphisms are associated with decreased overall cancer risk [16,17,18,19], while rs7421861 significantly augmented the risk of cancer [16].